-
- 抗原 See all VTCN1 抗体
- VTCN1 (V-Set Domain Containing T Cell Activation Inhibitor 1 (VTCN1))
-
适用
- 人
-
宿主
- 小鼠
-
克隆类型
- 单克隆
-
标记
- This VTCN1 antibody is un-conjugated
-
应用范围
- Immunohistochemistry (IHC), Flow Cytometry (FACS), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p))
- 品牌
- IHC-plus™
- 纯化方法
- Affinity purified
- 免疫原
- Human VTCN1
- 克隆位点
- H74
- 亚型
- IgG1 kappa
- Top Product
- Discover our top product VTCN1 Primary Antibody
-
-
- 应用备注
-
Approved: Flo, IHC, IHC-P (20 μg/mL)
Usage: This H74 antibody has been tested by flow cytometric analysis of transient hB7-H4 transfected cells. This can be used at less than or equal to 0.25 μg per test. A test is defined as the amount (ug) of antibody that will stain a cell sample in a final volume of 100 μL. Cell number should be determined empirically but can range from 10^5 to 10^8 cells/test. It is recommended that the antibody be carefully titrated for optimal performance in the assay of interest. - 说明
-
Target Species of Antibody: Human
- 限制
- 仅限研究用
-
- 状态
- Liquid
- 浓度
- Lot specific
- 缓冲液
- Aqueous buffer, 0.09 % sodium azide. Sourced from ascites.
- 储存液
- Sodium azide
- 注意事项
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- 储存条件
- 4 °C
- 储存方法
- Store at 2°C to 8°C.
-
-
The prognostic impact of B7-H3 and B7-H4 in head and neck squamous cell carcinoma." in: Journal of cancer research and clinical oncology, (2022) (PubMed).
: "
-
The prognostic impact of B7-H3 and B7-H4 in head and neck squamous cell carcinoma." in: Journal of cancer research and clinical oncology, (2022) (PubMed).
-
- 抗原
- VTCN1 (V-Set Domain Containing T Cell Activation Inhibitor 1 (VTCN1))
- 别名
- VTCN1 / B7-H4 (VTCN1 产品)
- 背景
-
Name/Gene ID: VTCN1
Synonyms: VTCN1, B7 superfamily member 1, B7 Superfamily, member 1, B7h.5, B7S1, B7H4, PRO1291, VCTN1, RP11-229A19.4, B7 family member, H4, B7-H4, B7X, Protein B7S1 - 基因ID
- 79679
- UniProt
- Q7Z7D3
-